JCRB0114 LC4-1
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0114 | Cell Name | LC4-1 |
|---|---|---|---|
| Profile | leukemia, acute non T lymphoblastic | Other Name | LC4-1 |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 13 |
| Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
| Case history | acute non-T cell lymphoblastic leukemia | Metastasis | No |
| Tissue Metastasized | Genetics | positive Ia,B4, negative B2,Tac,T3,T4,T8,T11 & M1 | |
| Life Span | infinite | Crisis PDL | |
| Morphology | lymphocyte-like | Character | E-rossette formation. D-J joinning. EBNA negative. |
| Classify | tumor | Established by | Mayumi,M. |
| Registered by | Mayumi,M. | Regulation for Distribution | Not regulated. |
| Comment | Year | ||
| Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | dilute 1/10 every 3-4 day |
| Cell Number on Passage | 1-2 x 10^5 cells/ml | Race | |
| CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | not tested | ||||||
| CMV | - | parvoB19 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| EBV | - | HBV | - | ||||||
| HHV6 | - | HTLV-1 | - | ||||||
| HHV7 | - | HTLV-2 | - | ||||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | NT | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:3115091 | Establishment of a common acute lymphoblastic leukemia cell line (LC4-1) and effects of phorbol myristate acetate (PMA) on the surface antigen expression of the cell line. Yoshimura T,Mayumi M,Yorifuji T,Kim KM,Heike T,Miyanomae T,Shinomiya K,Mikawa H Am J Hematol. 1987 Sep;26(1):47-54 |
| Images |
|---|
![]() ![]() |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0114 | Cell Name | |
|---|---|---|---|
| LOT No. | 06122002 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal bovine serum | Temperature | 37 C |
| Cell Density at Seeding | 1-2 x 10^5 cells/ml | Methods for Passages | Dilution |
| Doubling Time | Cell Number in Vial (cells/1ml) | 3.2 x 10^6 | |
| Viability at cell freezing (%) | 94 | Antibiotics Used | free |
| Passage Number | Unknown (P13 at cellbank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD, LD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS in RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0114 | Cell Name | LC4-1 |
|---|---|---|---|
| LOT No. | 051691 | Lot Specification | distribution |
| Medium | RPMI1640 + FCS 10% | Temperature | 37 C |
| Cell Density at Seeding | 1-2x10^6 cells/10cm dish | Methods for Passages | dilution 1/10 every 3-4 days |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 8.6x10^5 |
| Viability at cell freezing (%) | 88 | Antibiotics Used | free |
| Passage Number | P8* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | NT |
| Sterility: FUNGI | NT | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |

